Europe Micro Invasive Glaucoma Surgery Migs Devices Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 1,738.15 |
 TCAC |
% |
| Principaux acteurs du marché |
Marché européen des dispositifs de chirurgie micro-invasive du glaucome (MIGS), par type de produit (shunt MIGS, stent MIGS, trabectome, lame double Kahook, shunt tubulaire, micro-implants, microcathéters et autres), cible (réseau trabéculaire, espace suprachoroïdien, filtration sous-conjonctivale, réduction de la production aqueuse et autres), type de chirurgie (glaucome associé à la cataracte, glaucome autonome), type de glaucome (glaucome à angle ouvert, glaucome aigu à angle fermé, glaucome à tension normale, glaucome secondaire, glaucome pigmentaire et glaucome congénital), utilisateur final (service ambulatoire de l'hôpital (HOPD), cliniques d'ophtalmologie, centres de chirurgie ambulatoire (ASCS) et autres), canal de distribution (appel d'offres direct, ventes au détail et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché européen des dispositifs de chirurgie micro-invasive du glaucome (MIGS)
La chirurgie micro-invasive du glaucome (MIGS) est utilisée pour traiter le glaucome à angle ouvert. Au départ, pour traiter le glaucome à angle ouvert, on administrait des médicaments qui réduisaient la production d'humeur aqueuse ou augmentaient l'écoulement de l'humeur aqueuse. Pour le glaucome à angle ouvert léger à modéré, on pratiquait traditionnellement un traitement pharmacologique et au laser. Avec l'avènement des procédures de chirurgie micro-invasive du glaucome (MIGS), de nouvelles options ont été créées pour les personnes non aptes à la chirurgie conventionnelle. L'augmentation de la population gériatrique et l'augmentation des initiatives gouvernementales pour la prévention de la cécité devraient stimuler le marché. La transition rapide des médicaments contre le glaucome vers des chirurgies mini-invasives du glaucome pourrait créer des opportunités pour le fabricant de dispositifs MIGS.
Data Bridge Market Research analyse que le marché européen des dispositifs de chirurgie micro-invasive du glaucome (MIGS) devrait atteindre la valeur de 1 738,15 millions USD d'ici 2030, à un TCAC de 29,7 % au cours de la période de prévision 2023-2030. Le shunt MIGS représente le segment de type de produit le plus important du marché en raison de la demande croissante de dispositifs chirurgicaux mini-invasifs.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Type de produit (shunt MIGS, stent MIGS, trabectome, lame double Kahook, shunt tubulaire, micro-implants, microcathéters et autres), cible (réseau trabéculaire, espace suprachoroïdien, filtration sous-conjonctivale, réduction de la production aqueuse et autres), type de chirurgie (glaucome associé à la cataracte, glaucome autonome), type de glaucome (glaucome à angle ouvert, glaucome aigu à angle fermé, glaucome à tension normale, glaucome secondaire, glaucome pigmentaire et glaucome congénital), utilisateur final (service de consultation externe de l'hôpital (HOPD), cliniques d'ophtalmologie, centres de chirurgie ambulatoire (ASCS) et autres), canal de distribution (appel d'offres direct, vente au détail et autres) |
|
Pays couverts |
Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland and Rest of Europe |
|
Market Players Covered |
Glaukos corporation, AbbVie Inc., Alcon, Johnson & Johnson Vision Care Inc., Sight sciences, Inc., Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird |
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Definition
MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier, and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
The growing incidences of eye diseases, rising demand for micro invasive glaucoma surgery, rising number of players in the market, and novel product launches are also propelling the growth of the Europe micro invasive surgery device market (MIGS).
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growth in Popularity of Minimally Invasive Surgery
Glaucoma is the second most common cause of blindness. According to WHO, 4.5 million people are blind because of glaucoma. The only effective treatment of glaucoma is to lower intra-ocular pressure so that there is no damage to the optic nerve. Earlier, there were only three ways to treat glaucoma; medications, laser therapy, and in severe cases, incisional surgeries. The medicines have some drawbacks, like patient adherence and ocular toxicity. Also, these are costly and are only available to some in developing countries. Laser therapies, though, are non-invasive. They lose their effectiveness over the period. Incisional surgeries are the most effective treatment to lower intraocular pressure. Still, they can fail due to scarring, decreased quality of life due to bleb-related foreign body sensation, induced astigmatism, and secondary cataracts.
MIGS provide provides safer, less invasive means of reducing intraocular pressure. Also, they reduce the dependencies on medication. They have quicker recovery time and modest results compared to incisional surgeries. Hence, surgeons and patients are increasingly adopting these micro-invasive surgeries. Therefore, the growing popularity of minimally invasive surgery is expected to drive the market growth.
- Rise in Incidence of Glaucoma
The cause of irreversible global blindness is majorly glaucoma. A glaucoma is a group of eye disorders that have very little to no symptoms in the initial stage but afterward lead to damage of optic nerves, which can lead to vision loss or blindness. The prevalence of glaucoma has been increasing.
Improving the quality of life is instrumental to reducing the burden of glaucoma, as it has several severe risk factors. It is necessary to shift to revolutionary techniques like micro invasive glaucoma surgery to overcome it at an early stage. Therefore this creates a demand for MIGS devices; hence an increasing incidence of glaucoma is expected to act as a driver for the market.
Opportunity
-
Introduction of Technological Advanced Product
Glaucoma is a severe eye disease that can lead to vision loss if not controlled. It generally does not lead to blindness as it can be controlled by modern treatment and many options for preventing further damage. With the increased scientific developments, there has been a revolutionary change in the treatment of glaucoma. With the advent of micro-invasive glaucoma surgery, there is a paradigm shift in medicine as it can help in the treatment of glaucoma at an early stage and avoid the dependency on filtration surgeries like trabeculectomy. This also overcomes the risks associated with these incisional surgeries. There are various advancements in the treatment of glaucoma with MIGS.
These new technologies are safer, and they give modest to good results. Therefore these are being increasingly adopted by patients and surgeons. This creates an opportunity for manufacturers to produce more technologically advanced devices. Hence, introducing technologically advanced products might act as an opportunity for the market.
Restraints/ Challenges
-
Inadequate Reimbursement Scenario
Vision is on the line with glaucoma; many people continue to lose sight daily with this disease. Patients with mild to moderate glaucoma received medical therapy conventionally, and the surgical options were confined to people with severe glaucoma. However, there is a paradigm shift in the treatment of glaucoma with the introduction of MIGS devices. Advanced glaucoma damage can be avoided by performing micro invasive glaucoma surgery at an early stage.
The surgeons don’t prefer to use MIGS devices because the reimbursements are so low. When the people are not paid for it, they stop using it, and ultimately its production stops. Although MIGS devices are revolutionizing the treatment of glaucoma, the approval and payment by insurance companies of these devices are seen as an obstacle. Therefore, poor reimbursements are expected to be considered a restraint for the market.
- Lack of Skilled Professionals with Adequate Knowledge
Intra-ocular surgery is a very complex task as the work has to be done in smaller spaces adjacent to susceptible structures where any mistake can lead to permanent vision loss. This makes the presence of skilled professionals a necessity for the surgery. Performing MIGS requires an even higher skill level because it involves the treatment, working in smaller, more sensitive spaces within the eye, and learning a new proprioceptive skill, namely intraoperative surgical gonioscopic viewing of the angle. Though the presence of skilled professionals is highly required, there is an acute shortage of trained surgeons in developing countries.
Even more, scarcity can be observed in professionals specialized in ophthalmological surgery across the globe, making it a severe problem in treating glaucoma. As the numbers of surgeons are meager, the number of surgical procedures will be deficient; therefore, this is seen as an obstacle. Thus, a high level of market dependency on the availability of skilled professionals with adequate knowledge might challenge the market.
Recent Development
- In February 2022, Santen is launching an innovative, interactive medical education platform for healthcare professionals (HCPs). It gives ophthalmologists access to high-quality, personalized learning at their own pace. This will help increase awareness amongst healthcare professionals and lead to better treatment and growth for the company
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope
The Europe micro invasive glaucoma surgery (MIGS) devices market is categorized into six segments by product type, target, surgery type, glaucoma type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- Migs Stents
- Migs Shunts
- Trabectome
- Kahook Dual Blade
- Tube Shunt
- Micro Implants
- Micro Catheters
- Others
On the basis of product type, the Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS shunts, MIGS stents, trabectome, kahook dual blade, tube shunt, micro implants, micro catheters and others.
Target
- Trabecular Meshwork
- Suprachoroidal Space
- Subconjunctival Filtration
- Reducing aqueous Production
- Others
On the basis of target, the europe micro invasive glaucoma surgery (migs) devices market is segmented into the trabecular meshwork, suprachoroidal space, subconjunctival filtration, reducing aqueous production and others.
Surgery Type
- Glaucoma in Conjunction with Cataract
- Stand-alone Glaucoma
On the basis of surgery type, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma.
Glaucoma Type
- Open- angle Glaucoma
- Acute angle- closure Glaucoma
- Normal – tension Glaucoma
- Secondary Glaucoma
- Pigmentary Glaucoma
- Congenital Glaucoma
On the basis of glaucoma type, the europe micro invasive glaucoma surgery (migs) devices market is segmented into open angle glaucoma, acute angle closure glaucoma, normal tension glaucoma, secondary glaucoma, pigmentary glaucoma and congenital glaucoma.
End User
- Hospital Outpatient Departments (HOPD)
- Ophthalmology Clinics
- Ambulatory Surgery Centers (ASCS)
- Others
On the basis of end-user, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS), and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Others
On the basis of distribution channel, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into direct tender and retail sales.
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis/Insights
The Europe micro invasive glaucoma surgery (MIGS) devices market is categorized into six segments by product type, target, surgery type, glaucoma type, end user, and distribution channel.
The countries covered in this market report Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland and the rest of Europe.
Germany is dominating due to rise in prevalence of glaucoma or other related issues among the population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis
Europe micro invasive glaucoma surgery (MIGS) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R and D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe micro invasive glaucoma surgery (MIGS) devices market.
Certains des principaux acteurs opérant sur le marché européen des dispositifs de chirurgie micro-invasive du glaucome (MIGS) sont Glaukos Corporation, AbbVie Inc., Alcon, Johnson & Johnson Vision Care Inc., Sight Sciences, Inc., Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird et entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PRIMIUM INSIGHT
4.1 PESTEL
4.2 PORTER
5 VALUE CHAIN ANALYSIS
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACROECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
7 COST ANALYSIS BREAKDOWN
8 TECHNOLOGY ROADMAP
9 REIMBURSEMENT FRAMEWORK
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
11 REGULATION
12 MARKET OVERVIEW
12.1 DRIVERS
12.1.1 INCREASE IN THE GERIATRIC POPULATION
12.1.2 RISE IN INCIDENCE OF GLAUCOMA
12.1.3 GROWTH IN THE POPULARITY OF MINIMALLY INVASIVE SURGERY
12.2 RESTRAINTS
12.2.1 INADEQUATE REIMBURSEMENT SCENARIO
12.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
12.3 OPPORTUNITIES
12.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
12.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
12.4 CHALLENGES
12.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
12.4.2 RISKS ASSOCIATED WITH MICRO INVASIVE GLAUCOMA SURGERY
13 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE
13.1 OVERVIEW
13.2 MIGS STENTS
13.3 MIGS SHUNTS
13.4 TRABECTOME
13.5 KAHOOK DUAL BLADE
13.6 TUBE SHUNT
13.7 MICRO IMPLANTS
13.8 MICRO CATHETERS
13.9 OTHERS
14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
14.1 OVERVIEW
14.2 TRABECULAR MESHWORK
14.3 REDUCING AQUEOUS PRODUCTION
14.4 SUPRACHOROIDAL SPACE
14.5 SUBCONJUNCTIVAL FILTRATION
14.6 OTHERS
15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
15.1 OVERVIEW
15.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
15.3 STAND-ALONE GLAUCOMA
16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE
16.1 OVERVIEW
16.2 OPEN ANGLE GLAUCOMA
16.3 ACUTE ANGLE GLAUCOMA
16.4 NORMAL TENSION GLAUCOMA
16.5 SECONDARY GLAUCOMA
16.6 PIGMENTARY GLAUCOMA
16.7 CONGENITAL GLAUCOMA
17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
17.1 OVERVIEW
17.2 HOSPITAL OUTPATIENT DEPARTMENT (HOPD)
17.3 OPHTHALMOLOGY CLINICS
17.4 AMBULATORY SURGERY CENTERS (ASCS)
17.5 OTHERS
18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT TENDER
18.3 RETAIL SALES
18.4 OTHERS
19 EUROPE
19.1 GERMANY
19.2 U.K.
19.3 FRANCE
19.4 ITALY
19.5 RUSSIA
19.6 SPAIN
19.7 TURKEY
19.8 SWITZERLAND
19.9 NETHERLANDS
19.1 BELGIUM
19.11 DENMARK
19.12 POLAND
19.13 SWEDEN
19.14 NORWAY
19.15 FINLAND
19.16 REST OF EUROPE
20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: EUROPE
21 SWOT ANALYSIS
22 QUESTIONNAIRE
23 RELATED REPORTS
Liste des tableaux
TABLE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 10 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 12 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 13 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 15 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 16 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 18 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 24 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 26 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 27 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 29 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 30 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 32 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 33 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 35 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 36 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 37 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 38 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 39 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 43 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 44 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 46 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 47 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 49 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 52 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 53 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 54 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 55 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 56 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 61 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 63 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 64 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 66 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 69 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 71 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 72 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 73 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 74 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 75 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 77 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 80 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 81 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 83 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 84 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 86 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 87 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 88 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 90 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 95 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 97 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 98 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 100 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 101 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 103 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 104 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 105 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 106 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 107 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 108 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 109 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 110 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 111 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 112 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 114 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 117 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 120 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 122 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 123 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 124 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 125 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 128 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 129 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 131 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 132 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 134 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 135 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 137 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 138 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 139 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 140 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 141 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 143 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 145 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 146 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 147 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 148 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 149 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 151 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 152 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 154 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 156 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 158 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 162 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 165 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 168 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 171 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 173 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 174 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 175 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 176 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 179 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 180 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 182 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 183 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 185 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 186 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 188 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 189 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 190 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 191 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 192 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 194 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 196 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 197 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 199 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 200 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 202 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 203 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 205 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 206 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 207 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 208 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 209 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 210 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 211 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 213 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 216 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 219 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 222 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 223 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 224 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 225 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 226 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 228 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 230 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 231 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 233 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 234 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 236 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 237 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 239 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 240 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 241 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 242 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 243 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 244 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 245 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 247 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 248 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 250 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 251 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 253 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 254 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 256 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 257 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 258 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 259 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 260 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 264 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 267 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 270 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 271 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 273 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 274 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 275 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 276 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 277 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: EUROPE VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022
FIGURE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2023- 2030 (USD MILLION)
FIGURE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2023- 2030)
FIGURE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022
FIGURE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2022
FIGURE 27 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, CAGR (2023-2030)
FIGURE 29 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, LIFELINE CURVE
FIGURE 30 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022
FIGURE 31 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2023- 2030)
FIGURE 33 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
